AVEO Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,293 19,286 164,849 44,682
Cost of Revenue - - - -
Gross Profit 1,293 19,286 164,849 44,682
Operating Expenses
Research and Development 68,468 91,358 101,735 86,345
Sales, General and Admin. 28,712 36,932 29,167 14,763
Non-Recurring Items 8,017 2,633 - -
Other - - - -
Operating Income (103,904) (111,637) 33,947 (56,426)
Income From Continuing Operations
Add'l Income/Expense Items 2 744 537 1,026
Earnings Before Interest and Tax (103,902) (110,893) 34,484 (55,400)
Interest Expense 3,127 3,501 3,836 3,389
Earnings Before Tax (107,029) (114,394) 30,648 (58,789)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (107,029) (114,394) 30,648 (58,789)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (107,029) (114,394) 30,648 (58,789)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (107,029) (114,394) 30,648 (58,789)